Focalin (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Focalin drug offered from Novartis Pharmaceuticals Corporation. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | dexmethylphenidate hydrochloride |
SUBSTANCE NAME: | DEXMETHYLPHENIDATE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-11-30 |
END MARKETING DATE: | 0000-00-00 |
Focalin HUMAN PRESCRIPTION DRUG Details:
Item Description | Focalin from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2001-11-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0380_55c75ed8-eead-44a6-93bb-6a5010b2706d |
PRODUCT NDC: | 0078-0380 |
APPLICATION NUMBER: | NDA021278 |
Other DEXMETHYLPHENIDATE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: